Matches in Wikidata for { <http://www.wikidata.org/entity/Q33835874> ?p ?o ?g. }
- Q33835874 description "2017 nî lūn-bûn" @default.
- Q33835874 description "2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q33835874 description "2017 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q33835874 description "2017年の論文" @default.
- Q33835874 description "2017年論文" @default.
- Q33835874 description "2017年論文" @default.
- Q33835874 description "2017年論文" @default.
- Q33835874 description "2017年論文" @default.
- Q33835874 description "2017年論文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017年论文" @default.
- Q33835874 description "2017년 논문" @default.
- Q33835874 description "article científic" @default.
- Q33835874 description "article scientific" @default.
- Q33835874 description "article scientifique (publié 2017)" @default.
- Q33835874 description "articol științific" @default.
- Q33835874 description "articolo scientifico" @default.
- Q33835874 description "artigo científico (publicado na 2017)" @default.
- Q33835874 description "artigo científico (publicado na 2017)" @default.
- Q33835874 description "artigo científico" @default.
- Q33835874 description "artikull shkencor" @default.
- Q33835874 description "artikulong pang-agham" @default.
- Q33835874 description "artykuł naukowy" @default.
- Q33835874 description "artículo científico publicado en 2017" @default.
- Q33835874 description "artículu científicu espublizáu en 2017" @default.
- Q33835874 description "bilimsel makale" @default.
- Q33835874 description "bài báo khoa học" @default.
- Q33835874 description "mokslinis straipsnis" @default.
- Q33835874 description "naučni članak" @default.
- Q33835874 description "scienca artikolo" @default.
- Q33835874 description "scientific article" @default.
- Q33835874 description "teaduslik artikkel" @default.
- Q33835874 description "tieteellinen artikkeli" @default.
- Q33835874 description "tudományos cikk" @default.
- Q33835874 description "vedecký článok" @default.
- Q33835874 description "vetenskaplig artikel" @default.
- Q33835874 description "videnskabelig artikel (udgivet 2017)" @default.
- Q33835874 description "vitenskapelig artikkel" @default.
- Q33835874 description "vitskapeleg artikkel" @default.
- Q33835874 description "vědecký článek" @default.
- Q33835874 description "wetenschappelijk artikel" @default.
- Q33835874 description "wissenschaftlicher Artikel" @default.
- Q33835874 description "επιστημονικό άρθρο" @default.
- Q33835874 description "мақолаи илмӣ" @default.
- Q33835874 description "мақолаи илмӣ" @default.
- Q33835874 description "наукова стаття, опублікована у квітні 2017" @default.
- Q33835874 description "научна статия" @default.
- Q33835874 description "научная статья" @default.
- Q33835874 description "научни чланак" @default.
- Q33835874 description "научни чланак" @default.
- Q33835874 description "מאמר מדעי" @default.
- Q33835874 description "سائنسی مضمون" @default.
- Q33835874 description "مقالة علمية" @default.
- Q33835874 description "مقالهٔ علمی" @default.
- Q33835874 description "২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33835874 description "บทความทางวิทยาศาสตร์" @default.
- Q33835874 description "სამეცნიერო სტატია" @default.
- Q33835874 name "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 name "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 name "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 type Item @default.
- Q33835874 label "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 label "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 label "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 prefLabel "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 prefLabel "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 prefLabel "Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)" @default.
- Q33835874 P1433 Q33835874-CDCD524E-86C4-4756-98A5-FAAC305D2B93 @default.
- Q33835874 P1476 Q33835874-0BA851CB-8F32-465A-BC11-67999413CA06 @default.
- Q33835874 P2093 Q33835874-044F22EC-4FBA-4870-94C0-1DA982171D13 @default.
- Q33835874 P2093 Q33835874-0B185C16-9B54-4A9E-A5DA-108A3811E2A3 @default.
- Q33835874 P2093 Q33835874-2417FD8A-94B7-4D53-AD60-BB6C7D4EA07F @default.
- Q33835874 P2093 Q33835874-35F51BB1-941E-40FC-9D2B-E5B251F5FD2A @default.
- Q33835874 P2093 Q33835874-53D96853-16AF-4C56-8F8B-B459D76FAEE2 @default.
- Q33835874 P2093 Q33835874-672DE7BC-CEF2-41A2-A876-8EECA39093E6 @default.
- Q33835874 P2093 Q33835874-720A23C5-5AD2-4852-9DA2-498CE75E0F0A @default.
- Q33835874 P2093 Q33835874-AE6FA946-00BB-413C-9E7E-DA1DF7297E5D @default.
- Q33835874 P2093 Q33835874-C424548A-1ECB-4AB1-B6DE-88203F9F4114 @default.
- Q33835874 P2093 Q33835874-DC27F357-2419-495D-8344-DC7222EC632E @default.
- Q33835874 P2860 Q33835874-1363EA60-404A-4D91-A9CD-E891AAA08039 @default.
- Q33835874 P2860 Q33835874-157EA77B-8DD9-4D1F-A600-AC187751376E @default.
- Q33835874 P2860 Q33835874-1FB06540-3405-4306-BD37-030C93F80C6D @default.
- Q33835874 P2860 Q33835874-2317663A-337B-4540-8518-32FC99A01483 @default.
- Q33835874 P2860 Q33835874-27D005B9-175D-4594-A951-8D0C0B9FD60B @default.
- Q33835874 P2860 Q33835874-2887BEDE-3387-40E2-8617-C81A4BDC60DE @default.
- Q33835874 P2860 Q33835874-2AE51FCC-ED9E-4C01-AFDC-7283C40AC848 @default.
- Q33835874 P2860 Q33835874-2B827A86-8252-426E-885D-12A25280FEEC @default.
- Q33835874 P2860 Q33835874-2DABC53D-225D-4149-8A07-E226E5AF198D @default.
- Q33835874 P2860 Q33835874-3FD987C0-73B6-4DF2-8524-DF99293C4CB9 @default.
- Q33835874 P2860 Q33835874-54892092-0140-4C47-9A05-2BC2955D575F @default.
- Q33835874 P2860 Q33835874-65F57C09-9FE4-4240-8B20-1F7A2D20AFBC @default.
- Q33835874 P2860 Q33835874-70013065-387D-4875-9664-B5DEAC532D2C @default.
- Q33835874 P2860 Q33835874-7DDBBFE2-A324-409B-B5D9-36B1E7A2A721 @default.
- Q33835874 P2860 Q33835874-9B781176-E2D5-4EDF-96FF-76DB6FE1ED58 @default.
- Q33835874 P2860 Q33835874-A57A8BE5-6FE9-4F20-881F-FA56B617EFB4 @default.
- Q33835874 P2860 Q33835874-AED5BC1F-B50A-450A-862E-9D5EFFD104A7 @default.